Robaeys G, Grebely J, Mauss S, Bruggmann P, Moussalli J, De Gottardi A, et al. Recommendations for the management of hepatitis C virus infection among people who inject drugs. Clin Infect Dis. 2013;57(Suppl 2):S129–37 [cited 7 Dec 2015].
Article
Google Scholar
Roncero C, Vega P, Martinez-Raga J, Torrens M. Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment. Eur J Gastroenterol Hepatol. 2017;29:629–33.
Article
Google Scholar
Bielen R, Stumo SR, Halford R, Werling K, Reic T, Stöver H, et al. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries. Harm Reduct J. 2018;15. https://doi.org/10.1186/s12954-018-0230-1.
Wright N, Reimer J, Somaini L, Roncero C, Maremmani I, Simon N, et al. Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model. Eur J Gastroenterol Hepatol. 2017;29:1206–14.
Li V, Chen J. The burden of hepatitis C in the injection drug user population the framework of stigma. J Glob Health. 2014. Available from: http://www.ghjournal.org/the-burden-of-hepatitis-c-in-the-injection-drug-user-population/. [cited 30 Aug 2017].
Daley DC. Family and social aspects of substance use disorders and treatment. J Food Drug Anal. 2013;21. https://doi.org/10.1016/j.jfda.2013.09.038.
Bauld L, Hay G, McKell J, Carroll C. Problem drug users’ experiences of employment and the benefit system. 2010. ISBN 978 1 84712 729 7.
Google Scholar
National Institute on Drug Abuse. Heroin - What are the medical complications of chronic heroin use? Heroin Res Rep Ser. 2014. Available from: https://www.drugabuse.gov/publications/research-reports/heroin/what-are-medical-complications-chronic-heroin-use. [cited 11 Jan 2018].
Lang K, Neil J, Wright J, Dell CA, Berenbaum S, El-Aneed A. Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers. Subst Abuse Treat Prev Policy. 2013;8:35.
Article
Google Scholar
Larney S, Cama E, Nelson E, Larance B, Degenhardt L. A cross-sectional study of correlates of imprisonment in opioid-dependent men and women in New South Wales, Australia. Drug Alcohol Rev. 2016;35:686–92.
Article
Google Scholar
Bremer V, Cai W, Gassowski M, Haußig J, Marcus U, Nielsen Stine. Abschlussbericht der Studie “Drogen und chronische Infektionskrankheiten in Deutschland” (DRUCK-Studie). Berlin: Robert Koch-Institut; 2016. Available from: https://doi.org/10.17886/rkipubl-2016-007. [cited 31 December 2018].
Moazen B, Moghaddam SS, Silbernagl MA, Lot M, Bosworth RJ, Alammehrjerdi Z, et al. Prevalence of drug injection, sexual activity, tattooing, and piercing among prison inmates. Epidemiol Rev. 2018;40:1–12.
Article
Google Scholar
Lazarus JV, Safreed-Harmon K, Hetherington KL, Bromberg DJ, Ocampo D, Graf N, et al. Health outcomes for clients of needle and syringe programs in prisons. Epidemiol Rev. 2018;40. https://doi.org/10.1093/epirev/mxx019.
Bielen R, Stumo S, Halford R, Werling K, Reic T, Stöver H, et al. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries. Harm Reduct. J. 2018;15:25.
Dolan K, Wirtz AL, Moazen B, Ndeffo-mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388:1089–102.
Article
Google Scholar
Zampino R, Coppola N, Sagnelli C, Di CG, Sagnelli E. Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment. World J Hepatol. 2015;7:2323–30.
Article
Google Scholar
European Medicines Agency. European public assessment reports. Hepatitis C, Chronic; 2018. p. 3–5.
Google Scholar
Stone J, Martin NK, Hickman M, Hutchinson SJ, Aspinall E, Taylor A, et al. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland. Addiction. 2017;112:1302–14.
Article
Google Scholar
Mina MM, Herawati L, Butler T, Lloyd A. Hepatitis C in Australian prisons: a national needs assessment. Int J Prison Health. 2016;12:3–16.
Article
Google Scholar
Apsinall EJ, Mitchell W, Schofiled J, Cairns A, Lamond S, Bramley P, et al. A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy. J Viral Hepat. 2016;23:1009–16.
Article
Google Scholar
Médicos y Pacientes. La SESP vincula el fin de la hepatitis C a su detección en las cárceles. Madrid; 2018. Available from: http://www.medicosypacientes.com/articulo/la-sesp-vincula-el-fin-de-la-hepatitis-c-su-deteccion-en-las-carceles. [cited 31 December 2018].
Grupo Malalties Infecciosas Penitenciaries de ICS. Datos no publicados. Número de pacientes tratados en las prisiones dependientes de la administración catalana (31 Diciembre 2017). 2017.
Google Scholar
Conselleria de Sanitat Universal i Salut Pública. Antiviral Report for the Hepatitis C in the Community Valencia (01/01/2017 to 08/31/2017). 2017. Available from: http://www.san.gva.es/web_estatica/index_es.html. [cited 4 May 2018].
Google Scholar
Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934–9.
Article
Google Scholar
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Spain. Country Drug Report - Drug use and responses in prison. 2017. Available from: http://www.emcdda.europa.eu/countries/drug-reports/2017/spain/drug-use-response-in-prison_en. [cited 27 Apr 2018].
Google Scholar
Ministerio de Justica e Interior. Art. 208. Sec. 1. Decreto 190/1996, de 9 de febrero, por el que se aprueba el Reglamento Penitenciario. TITULO IX. De las prestaciones de la Administración Penitenciaria. 1996. Available from: http://noticias.juridicas.com/base_datos/Penal/rd190-1996.t9.html. [cited 9 Jan 2018].
Google Scholar
HM Prison Service. Prison Service Order ORDER NUMBER 3200 Health Promotion. 2003.
Google Scholar
Loi n° 94–43 du 18 janvier 1994 relative à la santé publique et à la protection sociale. 1994. Available from: https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000000728979. [cited 1 May 2018].
Ministero della Sanità. Ritorno della medicina penitenziaria a norma dell’articolo 5 della legge, 30 November 1998 n. 419. 1999.
Google Scholar
Bundesrecht. Allgemeine Regeln Strafvollzugsgesetz § 56 2009. http://www.buzer.de/gesetz/1310/a18531.htm.
Google Scholar
Ministerio de Sanidad SS e I. Plan estratégico para el abordaje de la hepatitis c en el sistema nacional de salud. Madrid. 2015. Available from: http://www.msssi.gob.es/ciudadanos/enfLesiones/enfTransmisibles/docs/plan_estrategico_hepatitis_C.pdf. [cited 31 December 2018].
Public Health England. Hepatitis C in England 2017 report :Working to eliminate hepatitis C as a major public health threat. 2017.
Google Scholar
Dhumeaux D. Prise en charge thérapeutique et suivi de l’ensemble des personnes infectées par le virus de l’hépatite C; 2016.
Google Scholar
NHS Commissioning DCCPT. Strategic direction for health services in the justice system: 2016-2020 Care not custody, care in custody, care after custody. p. 2016.
Cox J, Dhuny J, Dodd J. Hepatitis C prevention, diagnosis and treatment in prisons in England; 2016.
Google Scholar
Ministère des affaires socIales et de la santé M de la J. Stratégie Santé des personnes placées sous main de justice. 2017.
Google Scholar
Hillon P, Fontaine H, Hanslik B, Hézode C, de Lédinghen V, Pageaux G-P, et al. AFEF guidelines management of hepatitis C virus infection. 2015.
Google Scholar
Servizio Salute Mentale DP e S nelle C. Il percorso clinico-assistenziale per le persone detenute. 2015.
Google Scholar
Casa di Reclusione di Padova. Linee guida sull’HIV/AIDS e le epatiti in carcere. Milan; 1999. Available from http://www.ristretti.it/areestudio/salute/norme/guidaaids.htm.
Bessa CFB, Lazo GN, Sauret GV, Sauret GV. Improving prison conditions by strengthening the monitoring of HIV, HCV, TB and harm reduction mapping report - Catalonia (Spain) report by OSPDH -Observatory of the Penal System and Human Rights (University of Barcelona). Barcelona. 2015.
Saiz de la Hoya-zamácola P, Marco-Mouriño A, Clemente-Ricote G, Portilla-Sogorb J, Boix-Martínez V, Núñez-Martínez O, et al. Recomendaciones de expertos sobre el diagnóstico y tratamiento de la hepatitis C crónica en el medio penitenciario. Rev Esp Sanid Penit. 2007;9:27–38.
Article
Google Scholar
Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Noordegraaf-schouten MV, et al. Active case finding for communicable diseases in prison Settings: increasing testing coverage and uptake among the prison population in the European Union / European Economic Area. Epidemiol Rev. 2018;40. https://doi.org/10.1093/epirev/mxy001.
Public Health England. BBV bulletin: Special Edition. Quarterly update report of the introduction of opt-out BBV testing in prisons from PHE, NHS England and HMPPS. 2017. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/666850/BBV_bulletin_Dec_2017.pdf.
Google Scholar
Morey S, Hamood A, Valappip M, Jones D, Thompson C, Dhuny J, et al. A universal offer of blood borne virus testing substantially increases diagnosis and treatment of HCV in prisons. J Hepatol. 2018;68(1):s307-S308.
Ekeke N, Francis-Graham S, King T, Demma S, Macdonals D, Rosenberg W. Poster presented at EASL. Improving detection and management of HCV infection in prisons. EASL 2018 - Eur Assoc Study Liver; 2018. p. 2018.
Google Scholar
Remy A, Guillaume B, Arnaud H, Hakim B, Stéphane M. COMPASS project. Inside and outside link for inmates and PWID with hepatitis B or C in France, first results. Perpignan. 2016. Available from: https://www.eiseverywhere.com/file_uploads/7cfc55fea5c77cee07bfd9172010b3dd_Andr-JeanRemy-61.pdf.
Bouteille-Gaillet M. Prisons et comorbidités - Prise en charge de l’hépatite C en détention. 2016. Available from: http://vih.org/20160607/prise-en-charge-lhepatite-c-en-detention/138211. [cited 9 May 2018].
Google Scholar
Llerena S, Mateo M, Cobo C, Blasco A, Cabezas J, Lázaro P, Crespo J. Efficiency of a Telemedicine Program in the Management of Hepatitis C in Inmates. J Hepatol. 2018; 68(S1): 53A. Available from: https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.30256. [cited 31 December 2018].
Crespo J, Llerena S, Cobo C, Cabezas J. ¿ Es posible la eliminación del virus de la hepatitis C en el entorno penitenciario? Rev Esp Sanid Penit. 2017;19:70–3.
CAS
PubMed
Google Scholar
Generalitat de Catalunya. Descriptors estadistics serveis penitenciaris. 2017. Available from: http://www.gencat.cat/justicia/estadistiques_serveis_penitenciaris/12_pob.html. [cited 7 Mar 2018].
Google Scholar
Marco A, Valls I, Guerrero RA, Turu E. La eliminación de la hepatitis C en prisión es posible. Predicción de la eliminación en las prisiones de Cataluña (España); 2017.
Google Scholar
Informe General 2016. Ministerio del Interior Secretaría General de Instituciones Penitenciarias. 2016. Available from http://www.interior.gob.es/documents/642317/1202140/Informe_General_IIPP_2016_12615039X.pdf/3d3b743f-4527-453a-a185-2b3976f724bf. [cited 31 Dec 2018].
Tellez F. El especialista hospitalario. Estrategias para mejorar la coordinacion con otras unidades: Farmacia, prisiones, y centros de tratamientos de adicciones. Data presented at GEHEP-SEIMC. 2017. Available from: http://www.gehep2017.org/images/site/ponencias/03_Sabado_30/Sabado_10.30_11.30h/Conf_Especial_P_3_F_Tellez.pdf.
Google Scholar
De La Hoya PS, Marco A, García-Guerrero J, Rivera A. Hepatitis c and b prevalence in Spanish prisons. Eur J Clin Microbiol Infect Dis. 2011;30:857–62.
Article
Google Scholar
Murcia J, Portilla J, Bedia M, Palazon JM, Sanchez-Paya J, de la Hoya Saiz P, et al. Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison. Enferm Infecc Microbiol Clin. 2009;27:206–12.
Article
Google Scholar
Public Health England. Health and Justice Report 2014. London. p. 2015. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/562775/Health_and_justice_report_2014.PDF. [cited 31 December 2018].
Darke J, Cresswell T, McPherson S, Hamoodi A. Hepatitis C in a prison in the North East of England: What is the economic impact of the universal offer of testing and emergent medications? J Public Heal (United Kingdom). 2016;38:e554–62.
Google Scholar
Taylor A, Munro A, Allen E, Dunleavy K, Cameron S, Miller L. Hepatitis C prevalence and incidence among Scottish prisoners and staff views of its management. Final report. 2012.
Google Scholar
Duncan S, Sherrard J. Experience of Screening For Hepatitis C in an Oxfordshire Prison FREE; 2013. p. P3.442.
Google Scholar
Kirwan P, Evans B, Brant L. Hepatitis C and B testing in English prisons is low but increasing. J Public Health (Bangkok). 2011. https://doi.org/10.1093/pubmed/fdr011.
Meroueh F. HCV elimination in prison is feasible: a French experience. Presented at WHO Regional Office for Europe international meeting on prisons and health in joint collaboration with Public Health England (PHE) and European Monitoring Centre for Drugs and Drug A. 2017. Available from: https://justica.gov.pt/Portals/0/Programa%20do%20Encontro%20Internacional%20sobre%20a%20Saúde%20nas%20Prisões%20-%2011%20dez%2017.pdf?ver=2017-12-13-164252-827. [cited 10 May 2018].
Google Scholar
Jacomet C, Guyot-lénat A, Bonny C, Henquell C, Rude M, Dydymski S, et al. Addressing the challenges of chronic viral infections and addiction in prisons : the PRODEPIST study. Eur J Pub Health. 2016;26:122–8.
Article
Google Scholar
Semaille C, Le SY, Chiron E, Chemlal K, Valantin MA, Serre P, et al. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy separator commenting unavailable. Eurosurveillance. 2013;18. https://doi.org/10.2807/1560-7917.ES2013.18.28.20524.
Meroueh F. Traiter le VHC en prison: une initiative salutaire. Assoc pour la Commun sur les Prison l’incarcération en Eur. 2008. Available from: http://prison.eu.org/spip.php?article10630. [cited 9 May 2018].
Google Scholar
Roux P, Sagaon-Teyssier L, Lions C, Fugon L, Verger P, Carrieri MP. HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions. BMJ Open. 2014;4:1–10.
Article
Google Scholar
Verneuil L, Vidal JS, Ze Bekolo R, Vabret A, Petitjean J, Leclercq R, et al. Prevalence and risk factors of the whole spectrum of sexually transmitted diseases in male incoming prisoners in France. Eur J Clin Microbiol Infect Dis. 2009. https://doi.org/10.1007/s10096-008-0642-z.
Agenzia Regionale di Sanità dellaToscana. La salute dei detenuti in Italia: i risultati di uno studio multicentrico. Toscana; 2015. Available from: http://www.sanita24.ilsole24ore.com/pdf2010/Sanita2/_Oggetti_Correlati/Documenti/Regioni-e-Aziende/Carcere.pdf. [cited 31 December 2018].
Sagnelli E, Starnini G, Sagnelli C, Monarca R, Zumbo G, Pontali E, et al. Blood born viral infections, sexually transmitted diseases and latent tuberculosis in Italian prisons: a preliminary report of a large multicenter study. Eur Rev Med Pharmacol Sci. 2012;16:2142.
CAS
PubMed
Google Scholar
Brandolini M, Novati S, De Silvestri A, Tinelli C, Patruno SFA, Ranieri R, et al. Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting. BMC Public Health. 2013;13:981 [cited 9 Feb 2016].
Article
Google Scholar
La Torre G, Vezzo D, Arcese R. Occurrence and correlates of HIV and hepatitis B/C virus infections among prisoners of Southern Lazio, Italy; 2012.
Google Scholar
Voller F, Silvestri C, Orsini C, Aversa L, Da MF, Cipriani F. The health conditions of prison inmates in Tuscany. Epidemiol Prev. 2011;35:297–306.
PubMed
Google Scholar
Eckert J, Weilandt C. Infektionskrankheiten unter Gefangenen in Deutschland: Kenntnisse, Einstellungen und Risikoverhalten, Teilergebnisse des Projekts: “Infectious Diseases in German Prisons - Epidemiological and Sociological Surveys among Inmates and Staff”. Bonn; 2008. Available from: http://www.ahnrw.de/newsletter/upload/01_NL_ahnrw/2008/2008_10_01_NL20/Endbericht_Gefangene_060808_kompl.pdf. [cited 31 December 2018].
Radun D, Weilandt C, Eckert J, Schüttler C, Weid F, Kücherer C. Cross- sectional study on seroprevalence regarding hep b, hep c and hiv, risk behaviour, knowledge and attitudes about bloodbone infections among adult prisoners in Germany – Preliminary Results. Eur Sci Conf Appl Infect Dis Epidemiol - ESCAIDE. 2007; Available from: http://www.daignet.de/site-content/die-daig/fachorgan/pdfs/eur-j-med-res12-suppl-II-143.pdf. [cited 31 December 2018].
Schulte B, Stover H, Thane K, Schreiter C, Gansefort D, Reimer J. Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates. Int J Prison Health. 2009;5:39–44.
Article
CAS
Google Scholar
Meyer MF, Wedemeyer H, Monazahian M, Dressman J, Manns MP, Lehmann M. Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiol Infect. 2007. https://doi.org/10.1017/S0950268806006820.
Departament de Justícia. Descriptors estadistics de Serveis Penitenciaris I de Rehabilitació. 2018. Available from: http://www.gencat.cat/justicia/estadistiques_serveis_penitenciaris/1_pob.html. [cited 23 Apr 2018].
Google Scholar
Anuario Estadístico del Ministerio del Interior 2017. Ministerio del Interior. 2017. Available from http://www.interior.gob.es/documents/642317/1204854/Anuario_estadistico_2017_con_accesibilidad_EN_LINEA.pdf/09bb0218-7320-404c-9dd5-58f4edec914f. [cited 31 Dec 2018].
Offender Management Statistics. England & Wales prison population 2017. London; 2017. Available from: https://www.gov.uk/government/statistics/offender-management-statistics-quarterly-april-to-june-2017. [cited 31 December 2018].
Ministère de la Justice. Les chiffres-clés de la Justice 2017. Paris; 2017. Available from: http://www.justice.gouv.fr/art_pix/stat_Chiffres%20Cl%E9s%202017.pdf. [cited 31 December 2018].
Ministero Della Giustizia. Detenuti presenti - aggiornamento al 28 febbraio 2017 28. Statistiche. 2017. Available from: https://www.giustizia.it/giustizia/it/mg_1_14_1.page?facetNode_1=1_5_36&contentId=SST1315635&previsiousPage=mg_1_14. [cited 11 Jan 2018].
Google Scholar
Statistisches Bundesamt. Rechtspflege: Bestand der Gefangenen und Verwahrten in den deutschen Justizvollzugsanstalten nach ihrer Unterbringung auf Haftplätzen des geschlossenen und offenen Vollzugs jeweils zu den Stich- tagen 31, März, 31. August und 30. November eines Jahres. Wiesbaden; 2017. Available from: https://www.destatis.de/DE/ZahlenFakten/GesellschaftStaat/Bevoelkerung/Ehescheidungen/Tabellen/EhescheidungenKinder.html. [cited 31 December 2018].
Secreteria General de Instituciones Penitenciarias. Informe General 2016. Madrid; 2016.
Istituto Nazionale di Statistica. I Detenuti Nelle Carceri Italiane. Rome; 2015. Available from: http://www.istat.it. [cited 31 December 2018].
Bundesministerium für Gesundheit. Strategie zur Eindämmung von HIV, Hepatitis B und C und anderen sexuell übertragbaren Infektionen, BIS 2023 - Bedarfsorientiert, Integriert, Sektorübergreifend. Berlin; 2016. Available from: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/5_Publikationen/Praevention/Broschueren/Strategie_BIS_2030_HIV_HEP_STI.pdf. [cited 31 December 2018].
National institute for Health and Care Excellence. Physical health of people in prison. 2016. Available from: https://www.nice.org.uk/guidance/ng57.
Google Scholar
AFEF guidelines. Recommandations AFEF sur la prise en charge des hépatites virales C. Available from https://afef.asso.fr/wp-content/uploads/2018/06/Recoavril2016.pdf.
Sarzotti C, Unito DS. Interventi di riduzione del danno efficaci secondo le linee guida internazionali 2013. Torino; 2013.